₹ 926.50
6.55 (0.71%)
A
Aarti Pharma Labs
₹ 926.50
Aarti Pharma Labs Share Price Today
Aarti Pharma Labs (AARTIPHARM) share price is trading at ₹926.50 on the NSE as of November 4, 2026 at 03:50 PM, up by 0.71% from its previous close of ₹919.95. In todays trading session AARTIPHARM reached a high of 934.50 and low of 912.60. The average traded price for today is 921.81. The 50 DMA stands at 874.36 and 200 DMA is at 750.21. Looking at intraday trend, the stock is moving sideways.
Stock Overview
- Symbol : AARTIPHARM
- Open : ₹927.40
- Previous Close : ₹919.95
- Day's Range : ₹912.60 – ₹934.50
- 52-Week Range : ₹585.00 – ₹1,002.40
Get 20+ Chart Types, 180+ Indicators, 80+ Drawing Tools & Create Custom Indicators for FREE.
AARTIPHARM Stock Performance
Markets Today
High
934.50
Low
912.60
Open at
927.40
Prev Close
919.95
Volumes
3,52,298
Avg Price
921.81
Lower Circuit
741.20
Upper Circuit
1,111.80
Last Traded Details
Quantity
10
Time
15:50:24
Price Movement
Historical Performance
3 M High
1,002.40
3 M Low
670.65
1 Yr High
1,002.40
1 Yr Low
585.00
3 Yr High
1,002.40
3 Yr Low
380.05
5 Yr High
1,002.40
5 Yr Low
234.80
1-Year Performance
AARTIPHARM Pros and Cons
Consolidated operational revenue grows from ₹3,862 Cr to ₹5,358 Cr from Q1 FY26 to Q1 FY27, driving strong top-line momentum.
Xanthine derivatives revenue share rebounds from 49.6% to 57% from Q1 FY26 to Q1 FY27, highlighting segment resurgence.
Regulated market share expands from 49% to 58% from Q1 FY26 to Q1 FY27, confirming premium market penetration.
Profit after tax surges from ₹495 Cr to ₹761 Cr from Q1 FY26 to Q1 FY27, confirming bottom-line expansion.
Joint venture contribution turns positive, growing from a loss of ₹18 Cr to a gain of ₹74 Cr from Q1 FY26 to Q1 FY27, indicating successful partnership turnaround.
International sales share falls from 56% to 48% from Q1 FY26 to Q1 FY27, indicating export softness.
Operating expenses rise from ₹2,801 Cr to ₹4,032 Cr from Q1 FY26 to Q1 FY27, signaling cost inflation pressure.
API & Intermediates revenue share declines from 40.8% to 30% from Q1 FY26 to Q1 FY27, reflecting portfolio mix dilution.
Average trading volume drops from 496.56 to 267.71 from Q1 FY26 to Q1 FY27, warning of liquidity drain.
Depreciation and amortization increases from ₹228 Cr to ₹300 Cr from Q1 FY26 to Q1 FY27, signaling heavy capex depreciation burden.
AARTIPHARM Analyst Rating
Hold
Analysts have suggested that investors can
Hold this Stock
- By Refinitiv from 1 analysts
Buy
0%
Hold
100%
Sell
0%
Get forecast for Price, ROA & ROE based on analyst ratings.
AARTIPHARM Share Price History
AARTIPHARM Fundamentals
Company Valuation
Market Cap (₹ Cr.)
8,401
PE Ratio
32.50
PB Ratio
3.70
Dividend Yield
0.38%
ROE
8.22%
ROCE
11.00%
Book Value (₹)
248.65
Face Value (₹)
5.00
Analyse AARTIPHARM with 12+ custom fundamentals and financial ratios.
Share Holding Pattern
| Held By | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|
| Promoters | 42.88% | 43.10% | 43.08% | 42.86% | 39.66% |
| Domestic Institutional Investors (DII) | 6.96% | 7.66% | 7.41% | 7.22% | 8.40% |
| Foreign Institutional Investors (FII) | 8.02% | 7.68% | 8.39% | 8.17% | 8.15% |
| Public Investors | 35.39% | 34.85% | 34.29% | 34.39% | 35.65% |
| Government | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
Aarti Pharma Labs Return Calculator
Note: Past profits do not guarantee future returns.
AARTIPHARM Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
AARTIPHARM Technicals
Moving Averages
Technical Indicators
Summary of Technical Indicators for AARTIPHARM
Margin on AARTIPHARM
*Calculated on NSE. Applicable on all exchanges. Margins are subject to change from time to time or may be withdrawn under volatile market conditions. Intraday Orders are square-off automatically at 03:19 pm on NSE / BSE or on hitting 80% of margin utilisation (whichever earlier).
AARTIPHARM Financials Summary
In Crores
AARTIPHARM Financials
Income Statement
In Cr
Balance Sheet
In Cr
Cash Flow
In Cr
Corporate Actions
The above dates are ex-dates.
Check AARTIPHARM latest Company Filings, Investor Presentation & Conference Call details.
AARTIPHARM Revenue Growth
All values are in Crores
Revenue
Profit
Loss
AARTIPHARM Similar Stocks
FAQs on AARTIPHARM
What is the share price of Aarti Pharma Labs?
What is the 52W high and 52W low of Aarti Pharma Labs?
What is the return on Aarti Pharma Labs share?
- Past 1 year: 7.98%
- Past 3 years: 136.65%
- Past 5 years: 221.42%
What is the PE and PB Ratio of Aarti Pharma Labs?
What is the EPS of Aarti Pharma Labs?
What is the shareholding pattern of Aarti Pharma Labs?
- DIIs - 8.40%
- FII - 8.15%
- Promoters - 39.66%
- Public Investors 35.65%
- Goverenment - 0.01%
How to buy Aarti Pharma Labs shares online?
How to buy Aarti Pharma Labs shares on Dhan?
- Download the Dhan App to Open a Demat Account
- Navigate to the “Money Tab”
- Add money to your account
- Search for Aarti Pharma Labs share
- Tap on “Buy”
